Alexey G. Ryazanov (born October 14, 1962) is a USSR-born scientist who discovered protein alpha-kinases, professor of Pharmacology at Rutgers University. The team led by Ryazanov discovered a new class of protein kinases — alpha-kinases.[1] One of the alpha-kinases, elongation factor-2 kinase (eEF2 kinase), can regulate the global protein synthesis rate and is implicated in cancer and aging.[1]
Early life
Alexey G. Ryazanov was born on October 14, 1962.[citation needed]
Career
He is a biochemist and molecular biologist who discovered alpha-kinases,[2] a class of protein kinases that include elongation factor-2 kinase (eEF2K)[3] and channel-kinases TRPM6 and TRPM7.
Ryazanov and his colleagues demonstrated that eEF2K is a regulator of global protein synthesis[1] that plays a key role in the maintenance of quality and immortality of germ cells.[4] His laboratory also demonstrated that channel-kinase TRPM7 plays the central role in magnesium homeostasis.[5]
Between 2009 and 2013 Ryazanov and Alexander Chikunov conducted a large-scale study where they tested the effect of the large variety of drugs currently used in medicine on the lifespan of long-lived mice. This study which was conducted at the Jackson Laboratory revealed the major pharmacological mechanisms that can delay aging and extend lifespan.[7]